6Scott MG.Hypertriglyceridemia,insulin resistance,and the metabolic syndrme[J].Am J Csrdiol.1999;83(Suppl 2):25-9.
7Earl SF.The metabolic syndrme and C-reactive protein,fibrinogen,and leukocyte count:findings from the Third National Health and Nutrition Examination Survey[J].Atherosclerosis,2003;168(2):351-8.
二级参考文献16
1Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev, 1995,75 : 473-486.
2Defronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension,dyslipidemiaand atherosclerotic cardiovascular diseases. Diabetes Care, 1991,14: 173-174.
5Lee ZS;Critchley JA;Chan JC.Obesity is the key determinant of cardiovascular risk factors in the Hong Kong Chinese population:cross-sectional clinic-based study,2000.
6Han TS;Williams K;Sattar N.Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome:San Antonio Heart Study,2002.
7Third report of the National Cholesterol Education Program (NCEP).Expert panel on detection,evaluation and treatment of high blood cholesterol in adult(Adult treatment panol Ⅲ),Final Report,2002(106).
8Melanson KJ;Mcinnis KJ;Rippe JM.Obesity and cardiovascular disease risk:research update,2001.
9Barbieri M;Rizzo MR;Manzella D.Age-related insulin resistance:is it an obligatory findings? The lesson from healthy centenarians[J],2001(1).
3American DA. Standards of meadicalcarein diabetes[J]. Diabetes Care,2009,32:S13.
4American DA. Standards of medical care in diabetes[J]. Diabetes Care,2012,35:S11.
5Rivea J J,Choi K Yoon Y E,et al. Association between increasing levels of hemoglobin Alc and coronary atheroselerosis in asympto- matic individuals without diabetes mellitus[J]. Coron Artery Dis, 2010,21:157.
6Zhang Y, Hu G, Yuan Z, et al. Glycosylated hemoglobin in rela- tionship to cardiovascular outcomes and meta-anlysis[J]. Epub, 2012,8:9.
